Liehr H, Grün M, Seelig H P, Seelig R, Reutter W, Heine W D
Virchows Arch B Cell Pathol. 1978 Feb 14;26(4):331-44. doi: 10.1007/BF02889560.
In order to evaluate the pathogenesis of galactosamine hepatitis, the action of galactosamine on mast cells, and alteration in the complement system suring the course of this experimental injury were studied. It has been previously demonstrated that rat livers after colectomy are refractory to galactosamine-induced liver cell necrosis and inflammation. For this reason colectomized animals were used to see whether the biochemical alterations produced by this aminosugar and thought to be responsible for cell death developed. Results showed: 1. galactosamine potently degranulates mast cells in vivo and in vitro, 2. the complement system is a) activated during the course of galactosamine hepatitis, probably by circulating endotoxins, and b) is essential for liver cell death in galactosamine hepatitis, and 3. colectomy does not prevent biochemical changes known to occur during galactosamine metabolism. It is concluded that death of galactosamine-injured liver cells is triggered by extrahepatocellular mechanisms, which lead ultimately to an activated complement system by endotoxins. It is postulated that related mechanism may also occur in viral hepatitis and in fulminant hepatic failure in man.
为了评估氨基半乳糖肝炎的发病机制,研究了氨基半乳糖对肥大细胞的作用以及在这种实验性损伤过程中补体系统的变化。先前已证明,结肠切除术后的大鼠肝脏对氨基半乳糖诱导的肝细胞坏死和炎症具有抗性。因此,使用结肠切除的动物来观察这种氨基糖产生的、被认为是导致细胞死亡的生化变化是否会发生。结果显示:1. 氨基半乳糖在体内和体外均能有效地使肥大细胞脱颗粒;2. 补体系统a)在氨基半乳糖肝炎过程中被激活,可能是由循环内毒素激活的,并且b)在氨基半乳糖肝炎中对肝细胞死亡至关重要;3. 结肠切除术并不能阻止氨基半乳糖代谢过程中已知会发生的生化变化。结论是,氨基半乳糖损伤的肝细胞死亡是由肝外机制触发的,这些机制最终导致内毒素激活补体系统。据推测,相关机制也可能发生在人类的病毒性肝炎和暴发性肝衰竭中。